Your browser doesn't support javascript.
loading
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy.
Xu, Runxin; Weber, Marie-Christin; Hu, Xinkai; Neumann, Philipp-Alexander; Kamaly, Nazila.
Affiliation
  • Xu R; Imperial College London, Department of Chemistry, Molecular Sciences Research Hub, United Kingdom.
  • Weber MC; Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Surgery, Germany.
  • Hu X; Imperial College London, Department of Chemistry, Molecular Sciences Research Hub, United Kingdom.
  • Neumann PA; Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Surgery, Germany. Electronic address: philipp-alexander.neumann@tum.de.
  • Kamaly N; Imperial College London, Department of Chemistry, Molecular Sciences Research Hub, United Kingdom. Electronic address: nazila.kamaly@imperial.ac.uk.
Semin Immunol ; 61-64: 101664, 2022 11.
Article in En | MEDLINE | ID: mdl-36306664
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Annexin A1 / Lipoxins Limits: Humans Language: En Journal: Semin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2022 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Annexin A1 / Lipoxins Limits: Humans Language: En Journal: Semin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2022 Type: Article Affiliation country: United kingdom